Cargando…
COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?
COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the pandemic, is also a hotbed with the highest death rates for mucormycosis. Cancer, a ubiquitously present menace, also contri...
Autores principales: | Mahajan, Ishika, Ghose, Aruni, Gupta, Deepika, Manasvi, Manasi, Bhandari, Saisha, Das, Aparimita, Sanchez, Elisabet, Boussios, Stergios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320339/ https://www.ncbi.nlm.nih.gov/pubmed/35887616 http://dx.doi.org/10.3390/jpm12071119 |
Ejemplares similares
-
Efficacy and Safety of COVID-19 Vaccines—An Update
por: Sharma, Eshani, et al.
Publicado: (2022) -
Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy
por: Ghose, Aruni, et al.
Publicado: (2022) -
Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022) -
Primary neuroendocrine breast cancer—an unusual occurrence
por: Vinod, Anjana, et al.
Publicado: (2023) -
The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?
por: Revythis, Antonios, et al.
Publicado: (2021)